[Multicentre observational study of Phlebodia 600 in treatment of patients with CEAP class C0-C3 chronic venous diseases].

Autor: Stoĭko IM; National Medical Surgical Centre named after N.I. Pirogov under the RF Ministry of Public Health, Moscow, Russia., Talibov OB; Moscow State University of Medicine and Dentistry named after A.I. Evdokimov, Moscow, Russia., Iashkin MN; National Medical Surgical Centre named after N.I. Pirogov under the RF Ministry of Public Health, Moscow, Russia., Kudykin MN; Volga Region Federal Medical Research Centre of the RF Ministry of Public Health, Nizhny Novgorod, Russia., Belentsov SM; Medical Centre 'AngioLine', Ekaterinburg, Russia., Katel'nitskaia OV; Rostov Scientific Research Institute of Oncology, Rostov-on-Don, Russia., Suchkov IA; Ryazan State Medical University named after Academician I.P. Pavlov under the RF Ministry of Public Health, Ryazan, Russia., Tolstikhin VI; Department of Surgical Diseases, Krasnoyarsk State Medical University named after Professor V.F. Voino-Yasenetsky, Krasnoyarsk, Russia., Kletskin AÉ; Chair of Surgery of the Department of Advanced Medical Training, Nizhny Novgorod State Medical Academy, Nizhny Novgorod, Russia., Sevost'ianova KS; Centre of New Medical Technologies, Institute of Chemical Biology and Fundamental Medicine under the Siberian Branch of the Russian Academy of Sciences, Novosibirsk, Russia.

Publikováno v: Angiologiia i sosudistaia khirurgiia = Angiology and vascular surgery [Angiol Sosud Khir] 2018; Vol. 24 (1), pp. 107-114.